Literature DB >> 19339936

Kaposi's sarcoma-associated herpesvirus transmission and primary infection.

Rachel Bagni1, Denise Whitby.   

Abstract

PURPOSE OF REVIEW: Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, is the causal agent of Kaposi's sarcoma, one of the commonest cancers in HIV-infected individuals. Transmission and risk factors for infection by KSHV are not fully understood. The purpose of this review is to highlight recent advances in our understanding of KSHV transmission in various settings. RECENT
FINDINGS: KSHV and HIV are both common in southern Africa where KSHV infection occurs during childhood via saliva. HIV infection is a major risk factor for KSHV infection. In developed countries, KSHV transmission among men who have sex with men is related to sexual risk factors such as number of sexual partners and to sexual practices involving saliva. KSHV can be transmitted by transfusion of infected blood, but storage of blood products diminishes the risk.
SUMMARY: Recent reports have provided much additional insight into KSHV transmission in different populations, but have also provided a number of important questions for the research and public health communities. Most critically, the role of HIV in increasing risk for KSHV infection and the possible effects on KSHV prevalence, and consequently the incidence of Kaposi's sarcoma warrants urgent further study.

Entities:  

Mesh:

Year:  2009        PMID: 19339936     DOI: 10.1097/COH.0b013e32831add5a

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  19 in total

Review 1.  Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities.

Authors:  Susan E Krown
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

2.  18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.

Authors:  Mark N Polizzotto; Corina Millo; Thomas S Uldrick; Karen Aleman; Millie Whatley; Kathleen M Wyvill; Deirdre O'Mahony; Vickie Marshall; Denise Whitby; Roberto Maass-Moreno; Seth M Steinberg; Richard F Little; Robert Yarchoan
Journal:  J Infect Dis       Date:  2015-03-31       Impact factor: 5.226

3.  The Zambia Children's KS-HHV8 Study: rationale, study design, and study methods.

Authors:  Veenu Minhas; Kay L Crabtree; Ann Chao; Janet M Wojcicki; Adrian M Sifuniso; Catherine Nkonde; Chipepo Kankasa; Charles D Mitchell; Charles Wood
Journal:  Am J Epidemiol       Date:  2011-03-28       Impact factor: 4.897

4.  Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.

Authors:  Michael J Silverberg; Bryan Lau; Chad J Achenbach; Yuezhou Jing; Keri N Althoff; Gypsyamber D'Souza; Eric A Engels; Nancy A Hessol; John T Brooks; Ann N Burchell; M John Gill; James J Goedert; Robert Hogg; Michael A Horberg; Gregory D Kirk; Mari M Kitahata; Philip T Korthuis; William C Mathews; Angel Mayor; Sharada P Modur; Sonia Napravnik; Richard M Novak; Pragna Patel; Anita R Rachlis; Timothy R Sterling; James H Willig; Amy C Justice; Richard D Moore; Robert Dubrow
Journal:  Ann Intern Med       Date:  2015-10-06       Impact factor: 25.391

Review 5.  Prevalence of Kaposi's sarcoma-associated herpesvirus among intravenous drug users: a systematic review and meta-analysis.

Authors:  Qiwen Fang; Zhenqiu Liu; Zhijie Zhang; Yan Zeng; Tiejun Zhang
Journal:  Virol Sin       Date:  2017-10-13       Impact factor: 4.327

6.  Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.

Authors:  Stephen J Dollery; Rey J Santiago-Crespo; Lela Kardava; Susan Moir; Edward A Berger
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

7.  Seroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in Cameroon.

Authors:  Christelle Mbondji-Wonje; Viswanath Ragupathy; Sherwin Lee; Owen Wood; Bih Awazi; Indira K Hewlett
Journal:  Viruses       Date:  2013-09-19       Impact factor: 5.048

8.  Epidemiology of classic and AIDS-related Kaposi's sarcoma in the USA: incidence, survival, and geographical distribution from 1975 to 2005.

Authors:  A W Armstrong; K H Lam; E P Chase
Journal:  Epidemiol Infect       Date:  2012-03-12       Impact factor: 4.434

9.  Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women.

Authors:  Alison M Elliott; Denise Whitby; Robert Newton; Katie Wakeham; Emily L Webb; Ismail Sebina; Lawrence Muhangi; Wendell Miley; W Thomas Johnson; Juliet Ndibazza
Journal:  Infect Agent Cancer       Date:  2011-09-30       Impact factor: 2.965

10.  A heparan-dependent herpesvirus targets the olfactory neuroepithelium for host entry.

Authors:  Ricardo Milho; Bruno Frederico; Stacey Efstathiou; Philip G Stevenson
Journal:  PLoS Pathog       Date:  2012-11-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.